EP3154581

BLOCKING CD38 USING ANTI-CD38 F(AB')2 TO PROTECT NK CELLS

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    15.6.2015
  • EP published:
    20.2.2019
  • EP application number:
    15747597.1
  • Max expiry date:
    14.6.2035
  • Title:
    BLOCKING CD38 USING ANTI-CD38 F(AB')2 TO PROTECT NK CELLS

Timeline

Today
15.6.2015EP application
20.2.2019EP Publication

Owner

  • Name:
    The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
  • Address:
    National Institutes of Health Office of Technology Transfer 6011 Executive Boulevard Suite 325 MSC 7660, 20852-7660, Bethesda, MD, US
  • Name:
    Janssen Biotech, Inc.
  • Address:
    1400 Mckean Road, 19477, Spring House, PA, US

Inventor

  • Name:
    CHILDS, Richard, W.
  • Address:
    Bethesda, MD, US
  • Name:
    BERG, Maria
  • Address:
    Bethesda, MD, US
  • Name:
    CALDERON, Luis, Espinoza
  • Address:
    Bethesda, MD, US
  • Name:
    SASSER, Kate
  • Address:
    Spring House, PA, US
  • Name:
    ATTAR, Ricardo
  • Address:
    Spring House, PA, US

Priority

  • Number:
    201462012864 P
  • Date:
    16.6.2014
  • Country:
    US

Classification

  • Categories:
    A61K 39/395, C07K 16/28, A61P 35/00, A61P 37/00

Upload documents